- Home
- CRC vs SLNO Comparison
CRC vs SLNO Comparison
Compare CRC & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRC
- SLNO
- Stock Information
- Founded
- CRC 2014
- SLNO 1999
- Country
- CRC United States
- SLNO United States
- Employees
- CRC N/A
- SLNO N/A
- Industry
- CRC Oil & Gas Production
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CRC Energy
- SLNO Health Care
- Exchange
- CRC Nasdaq
- SLNO Nasdaq
- Market Cap
- CRC 4.2B
- SLNO 3.7B
- IPO Year
- CRC N/A
- SLNO 2014
- Fundamental
- Price
- CRC $46.25
- SLNO $46.98
- Analyst Decision
- CRC Strong Buy
- SLNO Strong Buy
- Analyst Count
- CRC 10
- SLNO 9
- Target Price
- CRC $65.40
- SLNO $114.89
- AVG Volume (30 Days)
- CRC 808.7K
- SLNO 2.2M
- Earning Date
- CRC 11-04-2025
- SLNO 11-04-2025
- Dividend Yield
- CRC 3.51%
- SLNO N/A
- EPS Growth
- CRC N/A
- SLNO N/A
- EPS
- CRC 4.29
- SLNO N/A
- Revenue
- CRC $3,505,000,000.00
- SLNO $98,675,000.00
- Revenue This Year
- CRC $21.19
- SLNO N/A
- Revenue Next Year
- CRC $0.82
- SLNO $181.30
- P/E Ratio
- CRC $10.76
- SLNO N/A
- Revenue Growth
- CRC 34.91
- SLNO N/A
- 52 Week Low
- CRC $30.97
- SLNO $41.50
- 52 Week High
- CRC $60.08
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- CRC 36.31
- SLNO 31.94
- Support Level
- CRC $45.11
- SLNO $66.12
- Resistance Level
- CRC $49.19
- SLNO $69.99
- Average True Range (ATR)
- CRC 1.38
- SLNO 3.71
- MACD
- CRC 0.02
- SLNO -2.47
- Stochastic Oscillator
- CRC 27.94
- SLNO 18.57
About CRC California Resources Corporation
California Resources Corp is an independent oil and natural gas exploration and production company operating properties exclusively within California. It provides affordable and reliable energy in a safe and responsible manner, to support and enhance the quality of life of Californians and the local communities in which the company operates. It has some of the lowest carbon intensity production in the United States and is focused on maximizing the value of its land, mineral, and technical resources for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.